An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to HIV-1-infection
Related studies linked through entity extraction aliases.
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
- Status
- UNKNOWN
- Phase
- PHASE4
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD
- Status
- UNKNOWN
- Phase
- NA
Cellular Pharmacology and Platelet Effects of Abacavir and Lamivudine Anabolites
- Status
- COMPLETED
- Phase
- N/A
Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection
- Status
- COMPLETED
- Phase
- PHASE4
Short Cycle Therapy in ART Regimens Containing Rilpivirine: Assessment of Patients' Satisfaction
- Status
- COMPLETED
- Phase
- NA
Impact of Rapid ART Initiation on Retention in Care in the Southern US
- Status
- COMPLETED
- Phase
- NA
HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy
- Status
- COMPLETED
- Phase
- NA
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
ART First-line Treatment Durability in Russia
- Status
- COMPLETED
- Phase
- N/A
Dolutegravir in Real Life in Lesotho
- Status
- COMPLETED
- Phase
- N/A
Genotype-Informed Versus Empiric Management of VirEmia
- Status
- COMPLETED
- Phase
- NA
Second-line Switch to Dolutegravir Study
- Status
- COMPLETED
- Phase
- PHASE4
Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).
- Status
- UNKNOWN
- Phase
- PHASE4
Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T
- Status
- TERMINATED
- Phase
- N/A
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
- Status
- RECRUITING
- Phase
- NA
Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based Regimen
- Status
- UNKNOWN
- Phase
- PHASE3
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV
- Status
- COMPLETED
- Phase
- PHASE2